查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768769

全球经导管心臟瓣膜市场

Transcatheter Heart Valves
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 247 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计 2030 年全球经导管心臟瓣膜市场规模将达 436 亿美元

全球经导管心臟瓣膜市场规模预计在2024年为173亿美元，到2030年将达到436亿美元，在2024-2030年的分析期间内，复合年增长率为16.6%。经导管主动脉瓣(TAV)是本报告分析的细分市场之一，预计其复合年增长率为16.9%，到分析期结束时规模将达到314亿美元。经导管二尖瓣(TMV)细分市场在分析期间的复合年增长率预计为15.9%。

美国市场预计将达到 44 亿美元，中国市场复合年增长率将达到 21.2%

美国经导管心臟瓣膜市场规模预计在2024年达到44亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到111亿美元，在2024-2030年的分析期间内，复合年增长率为21.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为11.6%和14.1%。在欧洲，预计德国市场的复合年增长率约为12.8%。

全球经导管心臟瓣膜市场－主要趋势与驱动因素摘要

为什么经导管心臟瓣膜会改变心臟科？

经导管心臟瓣膜代表了心臟病学领域的一项突破，为患有严重心臟瓣膜疾病（如主动脉瓣狭窄）的患者提供了一种可替代传统开胸手术的微创方法。与需要大胸部切口和人工心肺机的传统外科瓣膜置换术不同，经导管心臟瓣膜置换术术是透过小切口（通常在鼠蹊部或胸部）插入导管折迭式瓣膜。一旦到位，瓣膜就会扩张并立即开始工作，无需开胸手术即可恢復正常血流。这种方法大大减少了与传统手术相关的身体创伤和恢復时间，使其成为老年患者和不适合传统手术的高手术风险患者的可行选择。该领域的领先技术是经导管主动脉瓣置换术（TAVR），由于其与外科手术相比疗效可靠且併发症发生率低，已被广泛采用。 TAVR 的成功推动了其他心臟瓣膜（包括二尖瓣和三尖瓣）经导管解决方案的开发，扩大了经导管瓣膜介入治疗的范围。经导管心臟瓣膜缩短了住院时间，减轻了术后疼痛，并加快了恢復时间，不仅改善了患者的预后，也改变了心血管治疗的标准。

经导管心臟瓣膜创新如何塑造心臟照护的未来？

在材料科学、器械设计和手术程序进步的推动下，经导管心臟瓣膜领域正在经历快速创新，从而提高了这些救生器械的安全性、有效性和多功能性。最重要的创新之一是开发更耐用、更能适应复杂解剖结构的下一代经导管瓣膜。这些新器械采用了镍钛诺（一种形状记忆合金）等先进材料，使瓣膜能够自行扩张并更好地贴合患者的解剖结构，确保更好的贴合併降低洩漏和併发症的风险。另一项重要创新是使用组织工程和生物可吸收瓣膜组件，旨在提高瓣膜装置的长期性能并最大限度地降低钙化风险。此外，新的输送系统和较小的导管尺寸允许透过较小的血管进行操作，进一步降低了血管併发症的风险，并使得在进行这些手术时创伤更小。 3D超音波心动图和CT导引导航等影像技术的创新也提高了手术的精准度，使得瓣膜放置更加精确，并降低了併发症的风险。数位健康技术的整合也是一个主要趋势，一些设备整合了感测器和无线监控系统，可以提供有关瓣膜性能和患者健康状况的即时数据，从而实现主动管理和及时干预。

哪些挑战影响了经导管心臟瓣膜的采用和发展？

儘管经导管心臟瓣膜具有革命性的潜力，但其广泛应用和发展仍面临若干重大挑战。主要挑战之一是这些手术的高成本。经导管瓣膜置换术，尤其是 TAVR，是一个资源密集型过程，涉及昂贵的设备、专门的培训以及先进的成像和手术设备，这可能会限制其可及性，尤其是在低收入和农村地区。另一个挑战是患者选择和手术计划的复杂性。与在直接可视化下进行的传统外科瓣膜置换术不同，经导管手术严重依赖超音波心动图、 电脑断层扫描和萤光透视等成像方式来指导瓣膜放置。这需要高度的专业知识和精确的解剖评估，这给新操作员带来了陡峭的学习曲线，并使这些手术在经验不足的中心整合变得复杂。此外，经导管心臟瓣膜的长期耐用性仍然是一个问题，特别是对于可能比设备寿命更长的年轻患者。新材料和新设计旨在延长耐用性，但关于10-15年以上长期疗效的数据仍然有限，因此很难确定适合这些手术的最佳患者情况。导管插入过程中的併发症风险，例如瓣週漏、瓣膜血栓症和血管损伤，也构成可能影响患者预后的挑战。监管和报销问题也使情况更加复杂，经导管器械的核准和报销标准在不同地区通常存在显着差异。

哪些因素推动了经导管心臟瓣膜市场的成长？

经导管心臟瓣膜市场的成长受到多种因素的推动，包括心血管疾病盛行率上升、全球人口老化以及设备设计和程序的技术进步。主要驱动因素之一是主动脉瓣狭窄和其他心臟瓣膜疾病的盛行率不断上升，尤其是在老年人中，他们通常具有更高的手术风险，因此更有可能受益于微创经导管治疗。随着全球人口老化，对恢復更快、併发症更少的微创治疗的需求不断增加，使经导管心臟瓣膜成为越来越受欢迎的选择。另一个关键驱动因素是这些设备的临床适应症的扩大。经导管瓣膜置换术最初核准用于高风险手术候选人，现在也用于低风险患者，因为临床试验证明其结果与外科瓣膜置换术相当或更好。适应症的扩大显着扩大了可以治疗的患者群体，从而推动了市场成长。技术进步也在推动市场发展，可重设和可回收瓣膜、更小的输送系统以及先进的成像工具等创新技术使手术更加安全有效。此外，心臟团队协作方法的日益普及，即心臟病专家、外科医生和影像专家共同製定最佳治疗方案，正在改善患者的选择和手术效果，从而提高经导管介入治疗的整体成功率。在专业培训和教育计画的支持下，世界各地医院专门的经导管瓣膜计画不断涌现，透过建设必要的基础设施和专业知识，也促进了市场的成长。最后，人们对经导管心臟瓣膜益处的认识不断提高，加上一些地区优惠的报销政策，使得这些手术更容易获得，并推动了更高的采用率。综合起来，这些因素使经导管心臟瓣膜市场走上了强劲的成长轨道，并使其成为介入性心臟病学的重要组成部分。

部分

产品类型（经导管主动脉瓣 (TAV)、经导管二尖瓣 (TMV)）、最终使用者（医院、导管室）

受访公司范例

  • Boston Scientific Corporation
  • Bracco Group
  • Braile Biomedica
  • Direct Flow Medical
  • Edwards Lifesciences
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • St. Jude Medical
  • Symetis

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP17639

Global Transcatheter Heart Valves Market to Reach US$43.6 Billion by 2030

The global market for Transcatheter Heart Valves estimated at US$17.3 Billion in the year 2024, is expected to reach US$43.6 Billion by 2030, growing at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the end of the analysis period. Growth in the Transcatheter Mitral Valve (TMV) segment is estimated at 15.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.4 Billion While China is Forecast to Grow at 21.2% CAGR

The Transcatheter Heart Valves market in the U.S. is estimated at US$4.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.1 Billion by the year 2030 trailing a CAGR of 21.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.6% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.

Global Transcatheter Heart Valves Market - Key Trends and Drivers Summarized

What Makes Transcatheter Heart Valves a Game-Changing Advancement in Cardiology?

Transcatheter heart valves represent a groundbreaking advancement in the field of cardiology, offering a minimally invasive alternative to traditional open-heart surgery for patients suffering from severe heart valve diseases such as aortic stenosis. Unlike conventional surgical valve replacement procedures that require a large chest incision and a heart-lung machine, transcatheter heart valve procedures involve the insertion of a collapsible valve via a catheter, typically through a small incision in the groin or chest. Once in place, the valve expands and starts functioning immediately, restoring normal blood flow without the need for open-heart surgery. This approach significantly reduces the physical trauma and recovery time associated with traditional surgery, making it a viable option for elderly patients or those with high surgical risk who may not be candidates for conventional procedures. The primary technology in this field is Transcatheter Aortic Valve Replacement (TAVR), which has gained widespread adoption due to its proven efficacy and lower complication rates compared to surgical options. The success of TAVR has spurred the development of transcatheter solutions for other heart valves, including the mitral and tricuspid valves, expanding the therapeutic scope of transcatheter valve interventions. With shorter hospital stays, reduced postoperative pain, and faster recovery times, transcatheter heart valves are not only improving patient outcomes but are also transforming the standard of care in cardiovascular treatment.

How Are Innovations in Transcatheter Heart Valves Shaping the Future of Cardiac Care?

The field of transcatheter heart valves is witnessing rapid innovation, driven by advancements in material science, device design, and procedural techniques, which are enhancing the safety, efficacy, and versatility of these life-saving devices. One of the most significant innovations is the development of next-generation transcatheter valves that offer enhanced durability and adaptability to complex anatomies. These new devices incorporate advanced materials such as nitinol-a shape-memory alloy that allows the valves to be self-expanding and more conformable to the patient’s anatomy, ensuring a better fit and reducing the risk of leaks or complications. Another key innovation is the use of tissue-engineered and bioresorbable valve components, which aim to improve the long-term performance of the devices and minimize the risk of calcification. Furthermore, new delivery systems and smaller catheter sizes are making it possible to perform these procedures with even less trauma, allowing access through smaller vessels and further reducing the risk of vascular complications. Innovations in imaging technology, such as 3D echocardiography and CT-guided navigation, are also enhancing procedural precision, enabling more accurate placement of the valve and reducing the risk of complications. The integration of digital health technologies is another major trend, with some devices incorporating sensors and wireless monitoring systems that provide real-time data on valve performance and patient health, allowing for proactive management and timely interventions.

What Challenges Are Affecting the Adoption and Development of Transcatheter Heart Valves?

Despite their transformative potential, the adoption and development of transcatheter heart valves face several significant challenges that need to be addressed to optimize their use and expand their reach. One of the primary challenges is the high cost associated with these procedures. Transcatheter valve replacement, particularly TAVR, is a resource-intensive process that involves expensive devices, specialized training, and sophisticated imaging and procedural equipment, which can limit accessibility, especially in low-income and rural settings. Another challenge is the complexity of patient selection and procedural planning. Unlike traditional surgical valve replacement, which is performed under direct visualization, transcatheter procedures rely heavily on imaging modalities such as echocardiography, CT scans, and fluoroscopy to guide valve placement. This demands a high level of expertise and precise anatomical assessment, making the learning curve steep for new operators and complicating the integration of these procedures into less experienced centers. Additionally, the long-term durability of transcatheter heart valves remains a concern, especially for younger patients who may outlive the lifespan of the device. Although newer materials and designs are aimed at extending durability, data on long-term outcomes beyond 10-15 years is still limited, making it difficult to determine the optimal patient profile for these procedures. The risk of complications, such as paravalvular leak, valve thrombosis, or vascular damage during catheter insertion, also poses challenges that can impact patient outcomes. Regulatory hurdles and reimbursement issues also complicate the landscape, as the approval and reimbursement criteria for transcatheter devices are often vary significantly between regions.

What Factors Are Driving Growth in the Transcatheter Heart Valve Market?

The growth in the transcatheter heart valve market is driven by several factors, including the rising prevalence of cardiovascular diseases, an aging global population, and technological advancements in device design and procedural techniques. One of the primary drivers is the increasing incidence of aortic stenosis and other valvular heart diseases, particularly among the elderly, who are often at higher surgical risk and thus more likely to benefit from minimally invasive transcatheter options. As the global population ages, the demand for less invasive treatments that offer faster recovery and fewer complications is rising, making transcatheter heart valves an increasingly preferred choice. Another key driver is the expansion of clinical indications for these devices. Originally approved for high-risk surgical candidates, transcatheter valve replacement procedures are now being performed in lower-risk patients, following clinical trials that demonstrated comparable or superior outcomes to surgical valve replacement. This broadening of indications is significantly expanding the patient pool eligible for these treatments, driving market growth. Technological advancements are also propelling the market, with innovations such as repositionable and retrievable valves, smaller delivery systems, and advanced imaging tools that are making the procedures safer and more effective. Furthermore, the growing adoption of heart team approaches-where cardiologists, surgeons, and imaging specialists collaborate to determine the best treatment plan-has improved patient selection and procedural outcomes, enhancing the overall success rate of transcatheter interventions. The rise of dedicated transcatheter valve programs in hospitals around the world, supported by specialized training and educational initiatives, is also contributing to market growth by building the necessary infrastructure and expertise. Lastly, increasing awareness of the benefits of transcatheter heart valves, coupled with favorable reimbursement policies in several regions, is making these procedures more accessible and driving higher adoption rates. These factors collectively indicate a robust growth trajectory for the transcatheter heart valve market, positioning it as a key component of interventional cardiology.

SCOPE OF STUDY:

The report analyzes the Transcatheter Heart Valves market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Transcatheter Aortic Valve (TAV), Transcatheter Mitral Valve (TMV)); End-Use (Hospital, Cath lab)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 16 Featured) -

  • Boston Scientific Corporation
  • Bracco Group
  • Braile Biomedica
  • Direct Flow Medical
  • Edwards Lifesciences
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • St. Jude Medical
  • Symetis

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Transcatheter Heart Valves - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Aging Population Drive Demand for Transcatheter Heart Valve Procedures
    • Advancements in Valve Design and Delivery Systems Strengthen Business Case for Next-Generation Transcatheter Heart Valves
    • Growing Preference for Minimally Invasive Cardiac Interventions Expands Addressable Market for Transcatheter Heart Valves in High-Risk Patients
    • Shift towards Transcatheter Valve-in-Valve (ViV) Procedures Spurs Adoption for Complex and Repeat Interventions
    • Increasing Use of Transcatheter Aortic Valve Replacement (TAVR) Expands Market Potential in Treating Aortic Stenosis
    • Rising Adoption of Transcatheter Mitral Valve Replacement (TMVR) Propels Growth in Mitral Regurgitation Treatment
    • Growing Integration of Imaging and Navigation Technologies Enhances Precision and Success Rates of Transcatheter Valve Procedures
    • Rising Interest in Personalized and Patient-Specific Heart Valve Solutions Expands Market for Customizable Transcatheter Devices
    • Focus on Early Detection and Treatment of Heart Valve Disorders Propels Demand for Less Invasive Valve Replacement Solutions
    • Expanding Application of Transcatheter Heart Valves in Treating Congenital Heart Defects Sustains Market Growth in Pediatric and Adult Congenital Segments
    • Rising Focus on Expanding Indications Beyond Aortic and Mitral Valves Enhances Market Potential in Treating Tricuspid and Pulmonary Valve Diseases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Transcatheter Aortic Valve (TAV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Transcatheter Mitral Valve (TMV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Transcatheter Heart Valves Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cath lab by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • JAPAN
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • CHINA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • EUROPE
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • FRANCE
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • GERMANY
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Spain 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Russia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Australia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • INDIA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: India 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: South Korea 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Latin America 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Argentina 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Brazil 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Mexico 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Middle East 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Iran 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Israel 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: UAE 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • AFRICA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Africa 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030

IV. COMPETITION